PRICE T ROWE ASSOCIATES INC /MD/
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,175,126
+$30,988,176 QoQ
Shares Held
816,518
+1076.1% QoQ
Ownership
0.752%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 223 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. EWTX ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in EWTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,175,126 | 816,518 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,186,950 | 69,427 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,422,271 | 57,315 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $833,480 | 51,386 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $664,441 | 50,682 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,487,382 | 294,881 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $775,635 | 29,050 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $635,435 | 23,808 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $415,778 | 23,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $299,573 | 16,424 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,379,216 | 126,071 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $720,283 | 125,704 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $966,269 | 124,680 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $817,541 | 122,570 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,309,434 | 258,326 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,521,381 | 256,238 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,779,815 | 349,223 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,392,817 | 349,775 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||